Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study.
Marco FloridiaSerena DalzeroVania GiacometEnrica TamburriniGiulia MasuelliValeria SavasiArsenio SpinilloBeatrice TassisLaura FranceschettiAnna Maria Degli AntoniMatilde SansoneGiovanni GuaraldiAntonella VimercatiAlessandra MeloniMarina Ravizzanull nullPublished in: Infection (2020)
We found no major differences in a wide range of outcomes relevant for pregnant women with HIV. Such results are reassuring, and this information may be helpful in a context of preconception counseling when therapeutic choices for pregnancy are discussed between women and care providers.
Keyphrases
- hiv testing
- antiretroviral therapy
- hiv positive
- hiv infected
- pregnancy outcomes
- human immunodeficiency virus
- men who have sex with men
- hepatitis c virus
- hiv aids
- preterm birth
- healthcare
- pregnant women
- palliative care
- polycystic ovary syndrome
- metabolic syndrome
- pain management
- quality improvement
- insulin resistance
- social media